Data as of Dec 17
| +1.43 / +4.32%|
The 5 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 48.00, with a high estimate of 55.00 and a low estimate of 36.00. The median estimate represents a +39.01% increase from the last price of 34.53.
The current consensus among 5 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.